With the exception of increased duration of morphea, risk of recurrence is no different in adults and children, or between morphea subtypes, skin types, and medium- to high-dose regimens. Journal of the American Academy of Dermatology, 12/23/2013. (Also see: Morphea Treatments: Phototherapy, UVA, PUVA)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.